HPQ Silicon Closed over $1.0 Million Non-Brokered Private Placement

10 hours ago 2
(Left) Fumed Silica samples from test batch 7, (Middle) HPQ Endura+ batteries at HPQ office in Montreal, (Right) Metagene Hydrogen technology system in operation(Left) Fumed Silica samples from test batch 7, (Middle) HPQ Endura+ batteries at HPQ office in Montreal, (Right) Metagene Hydrogen technology system in operation GNW

Article content

New Funding will help advance the commercialization of core technology platforms

Financial Post

THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

SUBSCRIBE TO UNLOCK MORE ARTICLES

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

REGISTER / SIGN IN TO UNLOCK MORE ARTICLES

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account.
  • Share your thoughts and join the conversation in the comments.
  • Enjoy additional articles per month.
  • Get email updates from your favourite authors.

THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account
  • Share your thoughts and join the conversation in the comments
  • Enjoy additional articles per month
  • Get email updates from your favourite authors

Sign In or Create an Account

or

Article content

MONTREAL, Dec. 15, 2025 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, announced that it has closed a non-brokered private placement of 6,170,442 common shares at a price of $0.1625 per share, for gross proceeds of $1,002,696.83.

Article content

Article content

Article content

All securities issued under the private placement are subject to a statutory hold period of four months and one day from the closing date of the placement, in accordance with applicable Canadian securities laws. The placement remains subject to final acceptance by the TSX Venture Exchange.

Article content

By signing up you consent to receive the above newsletter from Postmedia Network Inc.

Article content

In connection with the private placement, HPQ will pay commissions by issuing 333,303 warrants to CI Investment Services Inc. Each warrant entitles the agent to purchase one common share at an exercise price of $0.18 per share for a period of 48 months from the closing date of the placement, subject to the same four-month-and-one-day hold period.

Article content

Use of proceeds:

Article content

In addition to general working capital and corporate purposes, the net proceeds from the financing will be strategically deployed to advance HPQ’s commercialization initiatives across its three core technology pillars:

Article content

  • Fumed Silica Reactor (FSR): focus on client-driven commercial scale-up opportunities and revenue generations pathways;
  • HPQ ENDURA+™: commercialization of HPQ ENDURA+™ cells and advancement of the NRCan-supported silicon-based anode material program;
  • METAGENE™: continue technology development and commercialization of the autonomous green hydrogen production platform.

Article content

Article content

Management Participation:

Article content

As part of the financing, Mr. Bernard Tourillon, Chairman, President, CEO, and Director, insider and related party of HPQ, directly or through entities under his control, subscribed for 615,384 common shares ($99,999.90). Following the closing of the private placement, Mr. Tourillon beneficially owns or controls, directly or indirectly, 22,796,794 common shares, representing approximately 5.29% of the Company’s issued and outstanding shares.

Article content

Mr. Tourillon’s participation constitutes a related-party transaction under Multilateral Instrument 61-101 and TSX Venture Exchange Policy 5.9. The Company relied on applicable exemptions from formal valuation and minority shareholder approval requirements, as the fair market value of the insider participation did not exceed 25% of the Company’s market capitalization. The Board of Directors approved the private placement, including insider participation.

Article content

Article content

Image 1_EN_FR_FSR_ENDURA+_METAGENE

Article content

Article content

(Left) Fumed Silica samples from test batch 7, (Middle) HPQ Endura+ batteries at HPQ office in Montreal,

Article content

Article content

(Right) Metagene Hydrogen technology system in operation

Read Entire Article